RAS inhibitors: potential for cancer therapeutics.

[1]  A. Kral,et al.  Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice , 1995, Nature Medicine.

[2]  Walter A. Korfmacher,et al.  Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. , 1998, Cancer research.

[3]  W. R. Bishop,et al.  K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors* , 1997, The Journal of Biological Chemistry.

[4]  C. Der,et al.  The Ras branch of small GTPases: Ras family members don't fall far from the tree. , 2000, Current opinion in cell biology.

[5]  G. Prendergast,et al.  Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment. , 1997, Cancer research.

[6]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[7]  P. Casey,et al.  p21ras is modified by a farnesyl isoprenoid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Y. Henis,et al.  Membrane Interactions of a Constitutively Active GFP-Ki-Ras 4B and Their Role in Signaling , 1999, The Journal of Biological Chemistry.

[9]  W. Kabsch,et al.  The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.

[10]  T. Möröy,et al.  Sulindac sulfide inhibits Ras signaling , 1998, Oncogene.

[11]  W. Kabsch,et al.  Guanosine triphosphatase stimulation of oncogenic Ras mutants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R L Smith,et al.  Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. , 1993, Science.

[13]  Y. Kloog,et al.  Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid (*) , 1995, The Journal of Biological Chemistry.

[14]  S. Sebti,et al.  GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. , 1997, Cancer research.

[15]  A. Levinson,et al.  Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. , 1993, Science.

[16]  Teruhiko Yoshida,et al.  Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. , 1995, Cancer research.

[17]  C. Der,et al.  Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Der,et al.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Urano,et al.  Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Marshall,et al.  All ras proteins are polyisoprenylated but only some are palmitoylated , 1989, Cell.

[21]  S. Shirasawa,et al.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. , 1993, Science.

[22]  H. Pehamberger,et al.  Novel Ras antagonist blocks human melanoma growth. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Prendergast,et al.  Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB , 1999, Molecular and Cellular Biology.

[24]  M. Coffey,et al.  Reovirus therapy of tumors with activated Ras pathway. , 1998, Science.

[25]  N. Rosen,et al.  A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. , 1995, Cancer research.

[26]  C. Der,et al.  Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? , 1997, Biochimica et biophysica acta.

[27]  W. R. Bishop,et al.  Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules* , 2000, The Journal of Biological Chemistry.

[28]  Y. Kloog,et al.  Concepts in Ras-directed therapy. , 1999, Expert opinion on investigational drugs.